We'll see near-record highs over the next few days.
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
SeattlePI.com
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a..